Media: Capital fund bids on Leo Pharma share
Leo Pharma is negotiating confidentially with an investor circle interested in buying into the firm, learns Børsen. The sales process is moving in the right direction, according to Leo Foundation.
BY IBEN SCHMIDT, TRANSLATED BY NIELSINE NIELSEN
Danish pharmaceutical firm Leo Pharma's owner, Leo Foundation, is negotiating with two capital funds which plan to buy 10-20 percent of the company at a billion-kroner figure, according to Danish business daily Børsen.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
